Sort
15,440 grants matching “organoids”
Implementation of a vaginal/rectal HIV transmission to model to evaluate microbic
$370,000J. Victor Garcia-Martinez · Univ Of North Carolina Chapel Hill · R33 · FY2009 · AI
Apical-basal polarity in tumor progression and metastasis
$369,990Jing Yang · University Of California, San Diego · R01 · FY2023 · CA
Apical-basal polarity in tumor progression and metastasis
$369,990Jing Yang · University Of California, San Diego · R01 · FY2022 · CA
Comprehensive genetic dissection of druggable KRAS targets
$369,932Steven D Leach · Dartmouth College · R01 · FY2019 · CA
Oncogenic mechanism of Sox2 in Rb-deficient tumors
$369,889Michael S. Kareta · Sanford Research/Usd · R01 · FY2023 · CA
Targeting Cancer through Suppressing Stress Induction of GRP78/BiP
$369,889Amy S Lee · University Of Southern California · R01 · FY2022 · CA
Mechanistic dissection and inhibitor targeting of autophagy in RAS driven cancers
$369,832Kirsten L Bryant · Univ Of North Carolina Chapel Hill · R37 · FY2020 · CA
Stepwise Coordination of Eye Morphogenesis by Extracellular Matrix
$369,813Kristen M Kwan · University Of Utah · R01 · FY2022 · EY
On the path to the clinic: Lead optimization and pathway analysis of the pancreatic cancer-selective drug conjugate SW V-49
$369,812William G Hawkins · Washington University · R01 · FY2019 · CA
Interstitial fibroblasts drive prostate branching morphogenesis
$369,807Douglas William Strand · Ut Southwestern Medical Center · R01 · FY2023 · DK
Project 2: Targeting N-Myc and EZH2-driven Castrate Resistant Prostate Cancer
$369,766David S. Rickman · Weill Medical Coll Of Cornell Univ · P50 · FY2018 · CA
Project 3: Modeling tumor evolution and drug response in bladder cancer organoids
$369,766Michael M. Shen · Columbia University Health Sciences · P01 · FY2018 · CA
Project 3: Modeling tumor evolution and drug response in bladder cancer organoids
$369,766Michael M. Shen · Columbia University Health Sciences · P01 · FY2021 · CA
Project 3: Modeling tumor evolution and drug response in bladder cancer organoids
$369,766Michael M. Shen · Columbia University Health Sciences · P01 · FY2020 · CA
Project 2: Functions of ARID1A in muscle invasive bladder cancer
$369,765Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2020 · CA
Project 2: Functions of ARID1A in muscle invasive bladder cancer
$369,765Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2018 · CA
Project 2: Functions of ARID1A in muscle invasive bladder cancer
$369,765Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2021 · CA
Trajectory and Architecture of Microenvironment-Mediated Resistance in AMLÂ
$369,603Anupriya Agarwal · Oregon Health & Science University · U54 · FY2022 · CA
Project 1: Biomimetic Interactions Between Bacterial Pathogens and the Gastrointestinal Epithelium
$369,503Manuel R Amieva · Stanford University · U19 · FY2023 · AI
Barrett's esophagus and progenitor cells at the squamous-columnar junction
$369,500Jianwen Que · Columbia University Health Sciences · R01 · FY2017 · DK
Insights to Noncoding Disease Variants using Mosaic Diseases
$369,482Bryan Sun · University Of California, San Diego · DP2 · FY2021 · HG
Microfluidic platform for solid tumor mechanics and invasion
$369,419Mingming Wu · Cornell University · R01 · FY2025 · CA
Targeting SUMO1 degradation for advanced colon cancer therapy
$369,353Anita Bellail · Indiana University Indianapolis · R01 · FY2022 · CA
Men of African Ancestry are primed for aggressive prostate cancer by high prostate androgens driven by vitamin D deficiency and megalin
$369,337Larisa Nonn · University Of Illinois At Chicago · R01 · FY2025 · CA
Project 2: Predicting Treatment Responses Using Single Cell RNA Sequencing and Bioengineered Patient-derived Organotypic Models of HNC
$369,242David J Beebe · University Of Wisconsin-Madison · P50 · FY2024 · CA